BioNTech Results Presentation Deck

Building a next generation immunotherapy company 10 ✓ ✓ Rapid progress in key pipeline programs in both oncology and infectious diseases Multiple data read-outs & late-stage trial starts anticipated in 2H 2020 Expanded transatlantic operations with newly established R&D hub in Cambridge, U.S. Strong momentum toward our vision of building a global immunotherapy company BIONTECH

View entire presentation